The OPS recommends applying the AstraZeneca vacancies to the time limits for possible adverse effects

La Panizición Panamericana de la Salud (OPS) recommends the best mercoles to apply the vacancas against the COVID-19 of AstraZeneca, A major overhaul of its possible findings with exceptional cases of blood clots and definitively suspended in Denmark by “infrequent” or “serious” secondary effects.

The director of the OPS, Carissa Etienne, dijo en rueda de pressa que el organismo, que is a regional agency of the World Health Organization (OMS), is waiting for the vigilance processes.

“Regulatory agencies stand auditing report infrequent blood clots between people with low levels of plaques revealed by solid vacancy vigilance systems, and we will make additional recommendations soon, ”he said.

“Mientras tanto, it is important to manage the AstraZeneca vehicles all donde are available ”, dijo.

“As many as 200 million people worldwide have been vaccinated against AstraZeneca’s COVID-19 and the information of effective adversaries are very infrequent ”, añadió.

Denmark decided to definitively launch the AstraZeneca vaccine for its small habitats without “grave” secondary effects, anunciaron este miércoles las autoridades sanitarias.

For the majority of European countries that have suspended the use of this vaccine have resumed their use, although establishing a limit of edad. Norway will announce its decision.

Experts in immunization of the OMS will take place the week before a causal angle between this vacancy and the appearance of coagulations considered “plausible but unconfirmed”, and agregaron que los casos informados eran “muy infrecuentes”.

The risk-benefit balance follows “very much in favor of the vacuna”, dijo entonces un portavoz de la OMS a la AFP.

The specialists indicate that continue examining new dates and publish new recommendations “if necessary”.

AstraZeneca’s viral vector immunization is now one critical part of the Covax map, the mechanism led by the OMS to acquire antiquated vehicles and guarantee its equitable access throughout the world.

Etienne dijo que, desde marzo, The OPS Rotary Foundation has helped distribute more than 60 million doses of Covax to 28 countries in the United States.

South Africa also renounces AstraZeneca in February, but for other reasons it is doubtful its efficiency is the variant that isolates the country.

United States, although Switzerland, has no authority, and Venezuela has not yet called its secondary effects.

With AFP information

SEGUIR LEYENDO: